In this episode, we have a compelling discussion focusing on weight management and medications. GLP-1s, are a class of medications generating a lot of buzz for their efficacy in weight loss and cardiometabolic outcomes. Through this conversation, we will explore the findings, eligibility criteria, supply challenges, cost management implications, and more. We'll also discuss the impact of GLP-1s on employers and strategies they can adopt to navigate this evolving healthcare landscape.

To provide insight on this topic, we are thrilled to be joined by Dr. Halperin, who is the Chief Medical Officer with Form Health.